Sameer Parikh

No bio available.

Financial relationships

  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    MingSight Pharmaceuticals
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Novalgen Limited
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Eli Lilly
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Ascentage Pharma
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    TG Therapeutics
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    Kite pharma
    Date added:
    01/19/2024
    Date updated:
    01/19/2024
  • Attribution:
    Self
    Nature of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Date added:
    01/19/2024
    Date updated:
    01/19/2024

Pages

Return to 13th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego